A thread on Indrayani Biotech ltd (IBL)
Marketcap: 270 cr
CMP : 78
#investing #microcaps #retweet
IBL was incorporated on 09th March 1992. In 2018 taken over by Mr. Kasiraman Sayee Sundar new promoter of the Company.
The promoter is aggressive as seen in the latest order book and venturing into new acquisitions.
Business :
The model is to identify and aggregate prospective MSMEs having the potential for high growth.
They aggregate such companies and take them in as a subsidiary of the parent entity, based on mutual agreement.
Single-specialty hospitals, Pharma, homecare services, Agriculture services, Food services, Biotech products, Dairy products, small multi-fuel industrial Boilers, and Green energy plants are some of the high-growth areas where they are looking to aggregate MSMEs.
The subsidiaries in turn enjoy the advantages of access to highly skilled centralized business enablers like legal, secretarial, human resources, and accounting functions.
IBL is venturing into three verticals.
1. Food and Hospitality, 2. Healthcare, 3. Engineering.
The strategy will be mainly an Aggregation of Businesses through mergers, acquisitions, and partnerships.
As the first step, IBL initiated a Scheme of Arrangement (SoA) between IBL with Helios Solution Limited (HSL) and A – Diet Express Hospitality Service Limited (ADEHSL).
HSL is into Power Electronics Products and ADEHSL is into Industrial Catering.adietexpress.com
IBL has partnered with Matrix Boilers Private Limited. They manufacture hybrid boilers and have patented technology in Boiler production. They have installed more than 750 boilers all over India.
IBL to Acquire 51% of Indian Pharmaceutical Company KNISS Laboratories.
Received Contract for Food Supply to Gautam Buddha University in India recently .
Company is operating at ath sales and OPM is healthy .
Recent developments only give me more confidence about this company and promoters.
Technically there is a reversal and a breakout.
MSMEs will be a critical sector for pushing India's growth in the next 5 years and companies like IBL will play a key role in giving them the platform to perform.
Let's hope the orders continue and IBL turns out to be 10 X in the coming years.
#retweet for max outreach .
Ibls wholly owned subsidiary, IBL Healthcare plans to acquire controlling stakes in M/S Peekay Mediequip Limited ("PML"). PML is a company that was under Corporate Insolvency Resolution Process (CIRP). The acquisition process will be completed over a maximum period of 4.5 years.
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.